“Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway”, NJPS, vol 40, số p.h 2, tr 251–262, tháng 12 2025, doi: 10.54548/.